Dec. 04, 2018
Section One Antibiotics:
Category | Type | Representative products | Analyses of market condition | Weekly trend |
Antibiotics | Sulfonamides | Sulfadiazine, sulfadimidine, etc. | The upstream raw material is steady in high level. Parts of products is increasing strongly. The current tight supply ease for a short time but the price is firming and will continue in high shocks. | Stable |
Quinolones | Ciprofloxacin, enrofloxacin, levofloxacin, etc. | For Enrofloxacin, its supply is normal with stable market, and its market shall be stable in the next one month. For Ciprofloxacin, there is stable demand with some stock, but the outlook of market is bearish. For Levofloxacin, it is quite stable. | Decreasing | |
Tetracyclines | Oxytetracycline hcl, doxycycline hyclate, etc. | The price of oxytetracycline was slightly decreased and tends to be stable.The price of oxytetracycline hydrochloride was slightly adjusted back to the market price, which was greatly affected by the upstream raw material oxytetracycline. The price continues to be at a high level before the end of the year.The price of doxycycline began to change this week, and market demand is sluggish with a bearish tone. | Decreasing | |
Penicillins | Amoxicillin, ampicillin, penicillin V potassium, etc. | The market of Amoxicillin is fluctuating with tight supply. Price rises slightly. | Rising | |
Cephalosporins | Cefradine, cefalexin, cefadroxil, etc. | The supply may not timely due to the environmental impact and the advent of heating seasons. NCPC stop offering Cefradine recently and the supply of cephalexin is very tight, however the price is decreasing slightly. The price for 7-ACA is stable, ceftriaxone sodium and cefotaxime sodium is stable. Other series products price is going up such as Cefuroxime sodium, cefoperazone sodium/sulbactam sodium, cefepime arginine, ceftazidime/sodium carbonate. Cefazolin sodium and Ceftizoxime sodium is in serious shortage and their price surge. | Stable | |
Amphenicols | Chloramphenicol, florfenicol | Normal supply, stable market | Stable | |
Macrolides | Erythromycin thiocyanate, azithromycin | Shrink demand in Erythromycin thiocyanate and Azithromycin, stable market. | Stable | |
Tylosin, tylosin tartrate granular and powder, tilmicosin, tilmicosin phosphate. | Stable market, normal supply. | Stable | ||
Lincosamides | Lincomycin, clindamycin | Enough stockts from over-capacity, manafacture implement overhaul now, its market price is expected to decrease a little. | Decreasing | |
Aminoglycosides | Streptomycin/dihydrostreptomycin, neomycin sulphate, gentamycin, spectinomycin, etc. | Streptomycin/dihydrostreptomycin: normal supply, stable price. Neomycin: parts of manufacturers halt production now result in tight supply and rising market later.Gentamicin/spectinomycin: normal supply, stable price. | Stable |
Section Two Vermifuges:
Category | Type | Representative products | Analyses of market condition | Weekly trend | |
Vermifuges | Nematode-repellent drugs | Benzimidazoles | Albendazole, fenbendazole, oxfendazole, flubendazole, etc. | Albendazole: The mfgs put back on production in succession, the output in the early stage is small, and the market continued to be bullish;Fenbendazole: The supply is particularly tight and the price is stable;Oxibendazole: At present, it is in tight supply since the mfghas insufficient raw materials, tight supply. | Rising |
Benzothiazoles | Levamisole, etc. | The market is stable now. Upstream and downstream products are interacted on each other. The price is stable by the support of all the mfg united. | Stable | ||
Tetrahydropyrimidine | Pyrantel pamoate, etc. | Stable market, normal supply. | Stable | ||
Antibiotics | Ivermectin, avermectin, moxidectin, etc. | The supply of Avermectin remains tight.The price for Ivermectin is increasing now with tight supply for a long time. | Stable | ||
Anti-tapeworm drug | Isoquinoline | Praziquantel, epsiprantel, etc. | Rising cost of raw materials, tight supply. | Stable | |
Anticoccidial drug | Quinolines | Decoquinate | Stable market, normal supply. | Stable | |
Triazines | Diclazuril, toltrazuril, etc | Stable market, the supply is a little bit tight. | Stable | ||
Pyridines and others | Clopidol , amprolium, etc | Clopidol: Stable market, normal supply.Amprolium: Stable market, tight supply. | Stable |
Section Three Vitamins:
Category | Products | Analyses of market condition | Weekly trend |
Vitamins | VB1 | Mfgs resumed normal production in October. The tight supply ease now for some sources. The transaction price is stable with a slight decline. | Stable |
VB2 | B2 (98%): goods are in short supply in the market, and the prices rise in high level. It is in a steady rise.B2 (80%): Mfgs stop offering now. There is enough ready goods in the market result in inadequate amount of actual transactions. | Stable | |
VB3 | The factory's raw material, methylpyridine, is in no supply now so parts of manufacturers producing Niacinamide offer no price now. Its price may be going up later. There are a lots of inquiries from the market with strong market. | Stable | |
VB5 | Part of mfgs stop offering now and the price is stable. | Stable | |
VB6 | Parts of factories restart now. Transaction price will be decline steadily. | Stable | |
VB9 | The supply of raw materials is so tight that the market attention has increased, and the market price of Folic acid rises slightly. | Rising | |
VB12 | The price is firm with stable trend. | Stable | |
VC | The price is relatively stable in the short term. | Stable | |
VA | Mfgs stop offering feed grade now and the price is rising | Rising | |
VE | The price of feed grade now is rising. | Rising | |
VH(VB7) | Previously, factories stopped to quote or raised the price slightly. Downstream enterprises are more active in replenishing goods because of the rising in raw material price; Now the mgfs stop offering now and the price is rising. | Rising | |
VK3 | Parts of factories stop production or in limited production; the current supply is tight. There are increasing attention due to its unstable market. | Stable |